CAJ | 학술논문

目的：观察中西医结合治疗溃疡性结肠炎的疗效及复发情况。方法：90例患者随机分为两组，对照组45例采用西药常规治疗，治疗组45例在西药常规治疗基础上口服参苓白术散加减煎剂；两组疗程均为4周，1个疗程后进行疗效评价，1年后观察复发率情况。结果：治疗组总疗效、结肠镜疗效均明显优于对照组（P<0.05）；两组治疗后主要症状改善、大便常规中的红细胞及白细胞数降低程度均较治疗前明显（P<0.05），两组间比较治疗组优于对照组（P<0.05）；1年后治疗组复发率19.4%，对照组复发率50.0%，两组复发率比较有显著性差异。结论：中西医结合治疗溃疡性结肠炎疗效显著，复发率低。
목적：관찰중서의결합치료궤양성결장염적료효급복발정황。방법：90례환자수궤분위량조，대조조45례채용서약상규치료，치료조45례재서약상규치료기출상구복삼령백술산가감전제；량조료정균위4주，1개료정후진행료효평개，1년후관찰복발솔정황。결과：치료조총료효、결장경료효균명현우우대조조（P<0.05）；량조치료후주요증상개선、대편상규중적홍세포급백세포수강저정도균교치료전명현（P<0.05），량조간비교치료조우우대조조（P<0.05）；1년후치료조복발솔19.4%，대조조복발솔50.0%，량조복발솔비교유현저성차이。결론：중서의결합치료궤양성결장염료효현저，복발솔저。
Objective: To evaluate clinical efficacy of the integrative medicine on colitis gravis. Methods: 90 patients were randomly divided into the control group (45 cases) and the treatment group (45 cases); the control group was given western medicine, and another group was given Shenling Baizhu San more; 4 weeks as 1 course. Efficacy was evaluated in 1 course and recurrence was observed in 1 year. Results: The total efficiency and colonoscopy effects in the treatment were obviously higher than that in the control (P<0.05). The treatment group was better than the control through comparison between two groups (P<0.05). Main symptoms, reduction of red blood cells and white blood cells in stool after treatment were obviously lower than that before treatment. The difference was statistically significant (P<0.05). Conclusion: The integrative medicine could improve clinical effects and reduce recurrence.